M&A TRANSACTION · 2018
GoodRx acquired by Silver Lake
$2.80B· 20.7x EBITDA
Target
GoodRx
Acquirer
Silver Lake
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$135.0M
Deal Value
$2.80B
EV/EBITDA
20.7x
Context
This $2.80B acquisition of GoodRx by Silver Lake sits in the pharmacy sub-vertical. The 20.7x EBITDA multiple paid in 2018 can be compared against the population median for pharmacy transactions of similar size on our Pharmacy valuation hub. Silver Lake is acquiring as a private equity buyer; see how PE acquirers typically price pharmacy businesses on our Pharmacy PE buyer-pool page.
Source
Data sourced from Press releases and reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the GoodRx acquisition.